HSF1: Essential for Myeloma Cell Survival and A Promising Therapeutic Target

PURPOSE: Myeloma is a plasma cell malignancy characterized by the overproduction of immunoglobulin and is therefore susceptible to therapies targeting protein homeostasis. We hypothesized that heat shock factor 1 (HSF1) was an attractive therapeutic target for myeloma due to its direct regulation of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Cancer Res
Päätekijät: Fok, Jacqueline H L, Hedayat, Somaieh, Zhang, Lei, Aronson, Lauren I., Mirabella, Fabio, Pawlyn, Charlotte, Bright, Michael D., Wardell, Christopher P., Keats, Jonathan J, De Billy, Emmanuel, Rye, Carl S., Chessum, Nicola E. A., Jones, Keith, Morgan, Gareth J., Eccles, Suzanne A., Workman, Paul, Davies, Faith E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420136/
https://ncbi.nlm.nih.gov/pubmed/29391353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-1594
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia